Global Herpes Treatment Market 2017-2021


◆タイトル:Global Herpes Treatment Market 2017-2021
◆調査・発行会社:Technavio (Infiniti Research Ltd.)
◆資料形式:PDF / 英語
Single User(1名利用)USD3,500 ⇒換算¥381,500見積依頼/購入/質問フォーム
Five User(~5名利用)USD4,000 ⇒換算¥436,000見積依頼/購入/質問フォーム
Enterprise License(全社内共有可)USD5,000 ⇒換算¥545,000見積依頼/購入/質問フォーム
※弊社H&Iグローバルリサーチ株式会社はTechnavio (Infiniti Research Ltd.)の日本における正規販売代理店です。



About Herpes TreatmentHerpesviruses belong to double-stranded DNA viruses, which are responsible for a large number of diseases in humans and animals. There are eight types of human herpesvirus (HHV) that affects humans. Among these, herpes simplex virus (HSV) and varicella-zoster virus (VZV) are the two most commonly found HHVs that causes severe infections in humans. HSV is further segmented into oral herpes and genital herpes.

Technavio’s analysts forecast the global herpes treatment market to grow at a CAGR of 12.97% during the period 2017-2021.

[Covered in this report]
The report covers the present scenario and the growth prospects of the global herpes treatment market for 2017-2021. To calculate the market size, the report considers the sales of both branded and generic drugs in herpes treatment market.

The market is divided into the following segments based on geography:
• Americas

Technavio’s report, Global Herpes Treatment Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

[Key vendors]
• Gilead
• GlaxoSmithKline
• Merck
• Novartis

[Other prominent vendors]
• Abbott
• Agenus
• Genocea
• Mylan
• Teva Pharmaceutical Industries
• Vical

[Market driver]
• Increasing prevalence of herpes infection
• For a full, detailed list, view our report

[Market challenge]
• Side effects of drugs
• For a full, detailed list, view our report

[Market trend]
• Emergence of novel therapies
• For a full, detailed list, view our report

[Key questions answered in this report]
• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

*** You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.


Table of Contents
PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction
• Market outline
• Disease overview

PART 05: Market introduction
• Market overview
• Market size and forecast
• Five forces analysis

PART 06: Pipeline landscape

PART 07: Market segmentation by virus type
• Herpes simplex
• Herpes zoster

PART 08: Geographical segmentation
• Herpes treatment market in Americas
• Herpes treatment market in EMEA
• Herpes treatment market in APAC

PART 09: Key leading count

PART 10: Drivers and challenges
• Market drivers
• Market challenges

PART 11: Market trends
• Emergence of novel therapies
• Increasing focus on vaccine development
• Increasing focus on drug development for pre-adolescent patients

PART 12: Vendor landscape
• Competitive scenario

PART 13: Key vendor analysis
• Gilead
• GlaxoSmithKline
• Merck
• Novartis
• Other prominent vendors

PART 14: Appendix
• List of abbreviations

[List of Exhibits]
Exhibit 01: Types of HHV
Exhibit 02: Symptoms of herpesvirus infection
Exhibit 03: Diagnosis and treatment of herpes
Exhibit 04: Global herpes treatment market snapshot
Exhibit 05: Global herpes treatment market 2016-2021 ($ millions)
Exhibit 06: Opportunity analysis: Global herpes treatment market
Exhibit 07: Five forces analysis
Exhibit 08: Key pipeline molecules by vendors
Exhibit 09: Key clinical trials
Exhibit 10: Global herpes treatment market by virus type
Exhibit 11: Global HSV treatment market
Exhibit 12: Market overview: Global HSV treatment market
Exhibit 13: Global oral herpes treatment market 2016-2021 ($ millions)
Exhibit 14: Global share of HSV-2 infection
Exhibit 15: Global genital herpes treatment market 2016-2021 ($ millions)
Exhibit 16: Global herpes zoster treatment market 2016-2021 ($ millions)
Exhibit 17: Segmentation of global herpes treatment market by geography 2016 and 2021
Exhibit 18: Global herpes treatment market revenue by geography 2016-2021 ($ millions)
Exhibit 19: Market scenario in Americas
Exhibit 20: Herpes treatment market in Americas 2016-2021 ($ millions)
Exhibit 21: Market scenario in EMEA
Exhibit 22: Herpes treatment market in EMEA 2016-2021 ($ millions)
Exhibit 23: Market scenario of APAC
Exhibit 24: Herpes treatment market in APAC 2016-2021 ($ millions)
Exhibit 25: Population at a higher risk of herpes
Exhibit 26: Percentage distribution of organ transplants in US 1988-2016
Exhibit 27: Competitive structure analysis of global herpes treatment market 2016
Exhibit 28: Strategic success factors of companies in global herpes treatment market
Exhibit 29: Gilead: Key highlights
Exhibit 30: Gilead: Strength assessment
Exhibit 31: Gilead: Strategy assessment
Exhibit 32: Gilead: Opportunity assessment
Exhibit 33: GlaxoSmithKline: Key highlights
Exhibit 34: GlaxoSmithKline: Strength assessment
Exhibit 35: GlaxoSmithKline: Strategy assessment
Exhibit 36: GlaxoSmithKline: Opportunity assessment
Exhibit 37: Merck: Key highlights
Exhibit 38: Merck: Strength assessment
Exhibit 39: Merck: Strategy assessment
Exhibit 40: Merck: Opportunity assessment
Exhibit 41: Novartis: Key highlights
Exhibit 42: Novartis: Strength assessment
Exhibit 43: Novartis: Strategy assessment
Exhibit 44: Novartis: Opportunity assessment


Gilead, GlaxoSmithKline, Merck, Novartis, Abbott, Agenus, Genocea, Mylan, Teva Pharmaceutical Industries, and Vical.





★調査レポート[ヘルペス治療の世界市場2017-2021] (Global Herpes Treatment Market 2017-2021 / IRTNTR13496)販売に関する免責事項
[ヘルペス治療の世界市場2017-2021] (Global Herpes Treatment Market 2017-2021 / IRTNTR13496)についてEメールでお問い合わせ